Drug Safety Concerns: Four Indian Pharma Companies Issue Recalls in Last Three Months
It’s been a rough start to 2025 for Indian pharmaceutical giants. Four of India’s biggest generic drug producers issued product recalls in the last three months.
China Drug Exports to U.S. Rise as America Reaches a Crossroads in Its Own Supply Shortfalls
In 2024, China and India accounted for 57.6% of total U.S. pharmaceutical imports by weight, highlighting the potential risks associated with such reliance. Growing U.S. dependence on China and India for widely-used generic pharmaceutical products creates serious risks to national security and patient safety when drugs are in short supply, or ineffective.
CPA Applauds Robert F. Kennedy, Jr’s Confirmation as HHS Secretary
For far too long, America has been at the mercy of foreign producers that routinely violate FDA safety regulations for life-saving medicines, generic drugs, and essential medical equipment.
As Food Imports Rise, FDA Drops Ball on Food Inspections Worldwide
Food imports into the U.S. are on the rise. The trend now is for agricultural commodity trade deficits, rather than surpluses, with key commodities like beef usually in a deficit. Despite the increase in food imports, the Food and Drug Administration conducted far fewer than the annual goal of 19,200 inspections, according to FDA data.
Customs Admits Yet Again That De Minimis is Loaded with Fake Goods, and Banned Goods
De minimis, a customs rule that allows for duty free shipment and minimal inspection if the overseas vendor claims the value is under $800, is a haven for contraband, whether it’s fake Nikes, childrens’ toys made of lead, or banned food products, Customs and Border Protect (CBP) admitted yet again.
Gina Raimondo Gets Letter In Support of Solar Tariffs from Steel Union Workers
Commerce Secretary Gina Raimondo was asked to impose anti-dumping and countervailing duties (AD/CVD) on Southeast Asian solar companies in a letter from the United Steelworkers Union (USW) on Aug. 27.
De Minimis Catastrophe Escalates: DOJ Indictments Laughed-Off, Amazon Moving to China, CBP Sued
The de minimis problem is getting worse. Consider this article a “Summer 2024” update of how the de minimis catastrophe continues to escalate.
Drug Shortages Increase Odds Of Patient Death; More Than Half of Drugs In Short Supply For Over 12 Months.
Drug shortages are becoming commonplace in the U.S. Data from a new pharmaceutical industry tracking firm, Qyobo, shows hundreds of drugs are still in short supply – some well over a year — and our dependence on imports grows, including from labs on the receiving end of lackluster FDA inspections.
Ohio’s Solar Manufacturers Deserve a Level Playing Field
China is flooding the global market with solar panels. It’s part of an aggressive strategy by Beijing to dominate the world’s solar industry.
How to Address America’s Historic Drug Shortage Crisis
The United States is facing an unprecedented drug shortage, with a record 323 active drug shortages at the start of 2024 — the highest number since 2001.
